Frontier Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-41,944
| Closed | -$3.44M | – | 271 |
|
|
2022
Q3 | $3.44M | Sell |
41,944
-223
| -0.5% | -$18.3K | 0.04% | 249 |
|
|
2022
Q2 | $2.85M | Sell |
42,167
-43,119
| -51% | -$2.92M | 0.03% | 262 |
|
|
2022
Q1 | $9.43M | Sell |
85,286
-27,074
| -24% | -$2.99M | 0.09% | 215 |
|
|
2021
Q4 | $10.8M | Buy |
112,360
+38,865
| +53% | +$3.75M | 0.09% | 216 |
|
|
2021
Q3 | $6.42M | Sell |
73,495
-25,768
| -26% | -$2.25M | 0.05% | 244 |
|
|
2021
Q2 | $15.4M | Buy |
99,263
+17,821
| +22% | +$2.76M | 0.11% | 203 |
|
|
2021
Q1 | $12.9M | Sell |
81,442
-127,063
| -61% | -$20.1M | 0.1% | 204 |
|
|
2020
Q4 | $48.4M | Sell |
208,505
-38,414
| -16% | -$8.92M | 0.36% | 105 |
|
|
2020
Q3 | $54.1M | Buy |
246,919
+60,886
| +33% | +$13.3M | 0.47% | 76 |
|
|
2020
Q2 | $52.9M | Buy |
186,033
+63,404
| +52% | +$18M | 0.47% | 76 |
|
|
2020
Q1 | $35.3M | Buy |
122,629
+54,686
| +80% | +$15.8M | 0.4% | 92 |
|
|
2019
Q4 | $19.5M | Sell |
67,943
-50,448
| -43% | -$14.5M | 0.14% | 178 |
|
|
2019
Q3 | $17.1M | Buy |
118,391
+72,867
| +160% | +$10.5M | 0.13% | 186 |
|
|
2019
Q2 | $4.09M | Sell |
45,524
-34
| -0.1% | -$3.06K | 0.03% | 266 |
|
|
2019
Q1 | $3.99M | Buy |
45,558
+34,498
| +312% | +$3.02M | 0.03% | 270 |
|
|
2018
Q4 | $1.55M | Sell |
11,060
-2,577
| -19% | -$362K | 0.01% | 280 |
|
|
2018
Q3 | $3.48M | Sell |
13,637
-6,832
| -33% | -$1.75M | 0.02% | 272 |
|
|
2018
Q2 | $5.22M | Buy |
+20,469
| New | +$5.22M | 0.04% | 260 |
|